Paper2448
Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine.
Lüllmann H and 2 others. CRC Crit Rev Toxicol, 1975. Cited by 208 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine. Papers, record 2448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2448
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Phospholipids | Major topic |
| Animals | |
| Antidepressive Agents, Tricyclic | |
| Chemical Phenomena | |
| Chemistry | |
| Chloroquine | |
| Chlorphentermine | |
| Cholesterol | |
| Depression, Chemical | |
| Drug Evaluation, Preclinical | |
| Guinea Pigs | |
| Piperazine | |
| Piperazines | |
| Rats | |
| Surface-Active Agents | |
| Tranquilizing Agents | |
| Vasodilator Agents |
Source PubMed
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 208 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41369775 | New approach methodologies for metabolic disruption: a high-throughput human liver cell phospholipidosis assay. | Arch Toxicol | 2026 | https://conductscience.org/library/papers/41369775 | PubMed |
| 40241898 | Amiodarone-related keratopathy and optic neuropathy: case report and literature review. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40241898 | PubMed |
| 38370571 | Hydroxychloroquine-Induced Renal Phospholipidosis: Case Report and Review of Differential Diagnoses. | Case Rep Nephrol Dial | 2024 | https://conductscience.org/library/papers/38370571 | PubMed |
| 38134445 | AMALPHI: A Machine Learning Platform for Predicting Drug-Induced PhospholIpidosis. | Mol Pharm | 2024 | https://conductscience.org/library/papers/38134445 | PubMed |
| 33306921 | Tafenoquine: a toxicity overview. | Expert Opin Drug Saf | 2021 | https://conductscience.org/library/papers/33306921 | PubMed |
| 33126762 | Identification of Iminium Intermediates Generation in the Metabolism of Tepotinib Using LC-MS/MS: In Silico and Practical Approaches to Bioactivation Pathway Elucidation. | Molecules | 2020 | https://conductscience.org/library/papers/33126762 | PubMed |
| 26544718 | Coadministration of Atorvastatin and Amiodarone Increases the Risk of Pulmonary Fibrosis in Rats. | Med Princ Pract | 2016 | https://conductscience.org/library/papers/26544718 | PubMed |
| 24980264 | Glucosylceramide and lysophosphatidylcholines as potential blood biomarkers for drug-induced hepatic phospholipidosis. | Toxicol Sci | 2014 | https://conductscience.org/library/papers/24980264 | PubMed |
| 24791065 | Pathology and Neurotoxicity in Dogs after Repeat Dose Exposure to a Serotonin 5-HT1B Inhibitor. | J Toxicol Pathol | 2014 | https://conductscience.org/library/papers/24791065 | PubMed |
| 22945602 | Identification of drugs inducing phospholipidosis by novel in vitro data. | ChemMedChem | 2012 | https://conductscience.org/library/papers/22945602 | PubMed |
| 22449202 | Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction. | Mol Pharm | 2012 | https://conductscience.org/library/papers/22449202 | PubMed |
| 21976946 | Vortex keratopathy in a patient receiving vandetanib for non-small cell lung cancer. | Korean J Ophthalmol | 2011 | https://conductscience.org/library/papers/21976946 | PubMed |
| 21779761 | Mechanisms for Kir channel inhibition by quinacrine: acute pore block of Kir2.x channels and interference in PIP2 interaction with Kir2.x and Kir6.2 channels. | Pflugers Arch | 2011 | https://conductscience.org/library/papers/21779761 | PubMed |
| 18604229 | Interaction with the hERG channel and cytotoxicity of amiodarone and amiodarone analogues. | Br J Pharmacol | 2008 | https://conductscience.org/library/papers/18604229 | PubMed |
| 10826129 | The anomalous pharmacokinetics of amiodarone explained by nonexponential tissue trapping. | J Pharmacokinet Biopharm | 1999 | https://conductscience.org/library/papers/10826129 | PubMed |
| 8858564 | Regulation of cardiolipin biosynthesis in the heart. | Mol Cell Biochem | 1996 | https://conductscience.org/library/papers/8858564 | PubMed |
| 7495377 | Lipidosis of the dorsal root ganglia in rats treated with an almitrine metabolite. | Arch Toxicol | 1995 | https://conductscience.org/library/papers/7495377 | PubMed |
| 7469944 | Experimental lipidosis of the inner ear. | Arch Otorhinolaryngol | 1980 | https://conductscience.org/library/papers/7469944 | PubMed |
| 7225310 | Tamoxifen retinopathy. | Br J Ophthalmol | 1981 | https://conductscience.org/library/papers/7225310 | PubMed |
| 7167207 | Adrenocortical function of rats under prolonged administration of lipidosis-inducing drugs. | Naunyn Schmiedebergs Arch Pharmacol | 1982 | https://conductscience.org/library/papers/7167207 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2448
GET https://conductscience.org/api/papers/v1/2448/cited_by?page=2